Metraipolis › archive › dc_2f7b689a839f

Formulation, Optimization, and Evaluation of Transferosomes Co-Loaded with Methotrexate and Sorafenib for Anti-Arthritic Activity — Europe PMC PMID:41012532

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012532
DOI
10.3390/pharmaceutics17091196
License (as archived)
solo-consultazione
Archived
2026-11-09T23:20:17.895Z
SHA-256 of the archived text
07826c7289af250ec48fb74c02fc7bc618ff0eb1ed4cec1f1e53e659e6e0d9ae
Stable URL of this page
https://metraipolis.com/documento/dc_2f7b689a839f

How to cite

Formulation, Optimization, and Evaluation of Transferosomes Co-Loaded with Methotrexate and Sorafenib for Anti-Arthritic Activity — Europe PMC PMID:41012532 — Europe PMC (en), https://europepmc.org/article/MED/41012532 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f7b689a839f (Metraipolis archive dc_2f7b689a839f, sha256 07826c7289af250ec48fb74c02fc7bc618ff0eb1ed4cec1f1e53e659e6e0d9ae)
BibTeX
@misc{dc2f7b689a839f,
  title = {Formulation, Optimization, and Evaluation of Transferosomes Co-Loaded with Methotrexate and Sorafenib for Anti-Arthritic Activity — Europe PMC PMID:41012532},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012532},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f7b689a839f; sha256 07826c7289af250ec48fb74c02fc7bc618ff0eb1ed4cec1f1e53e659e6e0d9ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012532. Agents can read the archived copy with the MCP tool read_document.